Allergic bronchopulmonary aspergillosis

Area of Science:

• Pulmonology
• Allergy and Immunology
• Medical Mycology

Background:

• Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity response to Aspergillus fumigatus.
• It commonly complicates asthma and cystic fibrosis, leading to significant morbidity.
• The pathogenesis of Aspergillus fumigatus growth in bronchial mucus remains unclear.

Purpose of the Study:

• To review the clinical, radiologic, investigational, pathogenetic, and treatment aspects of ABPA.
• To highlight diagnostic utility of specific biomarkers and imaging modalities.
• To discuss current and potential therapeutic strategies.

Main Methods:

• Review of existing literature on ABPA.
• Analysis of diagnostic criteria including serological markers and imaging.
• Discussion of treatment modalities, including corticosteroid therapy.

Main Results:

• Elevated total serum IgE is nonspecific, but IgE antibodies to A. fumigatus are diagnostically useful.
• High-resolution computed tomography (HRCT) reveals bronchiectasis in most ABPA patients.
• Prednisone is effective but not always required long-term.

Conclusions:

• ABPA diagnosis relies on a combination of clinical, immunological, and radiological findings.
• Understanding Aspergillus fumigatus survival factors is crucial for targeted therapies.
• Current management focuses on immune suppression and airway clearance.